Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,209,216,259
+$256,004,787 QoQ
Shares Held
4,805,342
+9.6% QoQ
Ownership
0.272%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#40
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $6,692,750,905 across 9 Drug Manufacturers - General names. ABBV ranks #3 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,477,275 | $1,771,888,099 | |
| 2 | JNJ |
Johnson & Johnson
|
5,024,318 | $1,276,026,041 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,805,342 | $1,209,216,259 | |
| 4 | AMGN |
Amgen Inc
|
2,239,516 | $810,973,532 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,152,239 | $650,933,874 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,052,294 | $463,973,179 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,503,750 | $450,231,874 | |
| 8 | PFE |
Pfizer Inc
|
2,318,237 | $55,823,144 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,209,216,259 | 4,805,342 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $953,211,472 | 4,382,783 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $948,224,130 | 4,149,959 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $1,040,901,498 | 4,495,558 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $833,336,719 | 4,489,477 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $854,901,730 | 4,080,287 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $531,986,530 | 2,993,734 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $495,729,895 | 2,510,279 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $643,915,409 | 3,754,171 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $748,564,115 | 4,110,731 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $682,021,730 | 4,400,992 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $679,667,987 | 4,559,694 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $579,925,210 | 4,304,351 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $596,743,274 | 3,744,389 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $592,670,413 | 3,667,288 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $495,624,780 | 3,692,905 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $582,913,328 | 3,805,911 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $651,279,032 | 4,017,513 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $521,951,022 | 3,854,882 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $394,192,469 | 3,654,329 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $413,813,452 | 3,673,770 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $371,865,239 | 3,436,197 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $382,817,483 | 3,572,725 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $281,856,736 | 3,217,910 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $585,606,980 | 5,964,626 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $183,140,264 | 2,403,731 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||